TALARIS THERAPEUTICS TALS 深 沪
等待开盘 02-05 09:30:00 美东时间
2.72
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 2.72
- 总市值 1.20亿
- 52周最高 17.782
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 -6.218
- 委 比 0.00%
- 总股本 4396.06万
- 历史最高 183.082
- 量 比 0
- 振 幅 0.00%
- 历史最低 -6.218
- 每 手 1
- 风险率 0.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tourmaline Bio highlights positive phase 2 pacibekitug data
Tourmaline Bio (NASDAQ:TRML) on Sunday presented additional data from its ongoing Phase 2 TRANQUILITY trial of Pacibekitug in a poster presentation at the European Society of Cardiology (ESC) Congress...
2025-09-01 14:41
50%关税“炸弹”来袭！特朗普大棒挥向铜板块，哪些港美概念股值得关注
全球铜价破天荒创历史新高！三家大行对铜矿企业均维持长期乐观预期，大摩甚至建议逢低买入中资铜矿龙头，这些概念股值得关注>>
2025-07-10 20:44
Tourmaline Bio posts mid-stage data for anti-inflammatory agent
Shares of Tourmaline Bio (NASDAQ:TRML) fell in the premarket on Tuesday after the company posted topline data from a mid-stage trial for its lead candidate, pacibekitug, in patients with elevated high...
2025-05-20 20:17
Talaris Therapeutics GAAP EPS of -$0.89
Talaris Therapeutics press release (NASDAQ:TRML): Q1 GAAP EPS of -$0.89. – Cash, cash equivalents, and investments of $275.3 million as of March 31, 2025 provide expected cash runway into the second h...
2025-05-02 22:25
Talaris Therapeutics GAAP EPS of -$0.86
Talaris Therapeutics press release (NASDAQ:TRML): Q4 GAAP EPS of -$0.86. Cash, cash equivalents and investments were $294.9 million as of December 31, 2024, as compared to $203.0 million as of Decembe...
2025-03-13 21:19
Tourmaline Bio rises as Wedbush initiates with Outperform
Tourmaline Bio (NASDAQ:TRML) has been initiated at Wedbush with Outperform rating as it believes the compay's heart disease treatment has potential. The company's stock is up about 10%. Wedbush said t...
2025-03-07 03:39
Tourmaline Bio stock slides 7% amid news of CMO's departure
Tourmaline Bio (NASDAQ:TRML) shares were down 7% early Friday, the day after the company disclosed that its chief medical officer was leaving the company. In an SEC filing on Thursday, Tourmaline (TRM...
2024-10-11 22:39
Tourmaline Bio promotes Ryan Robinson to CFO post
Biotechnology company Tourmaline Bio (NASDAQ:TRML) said on Thursday that Ryan Robinson has been promoted to the post of CFO and treasurer, effective June 25. TRML shares were trading -2.49% pre-market...
2024-06-27 20:23
Cullinan Therapeutics appoints CFO
Biopharmaceutical company Cullinan Therapeutics (NASDAQ:CGEM) said on Monday that Mary Kay Fenton has been appointed CFO, beginning April 29. Fenton, most recently, served as interim CEO and CFO at Ta...
2024-04-29 19:58
Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware.
2023-10-18 20:18
